CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 20 enrolled
Drug / intervention
Podimetrics SmartMatdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05968924
NCT05968924N/ACompleted
CompareCT.gov

Improving DFU Outcomes: Early Detection of Foot Ulcers Using Novel Technology

Montefiore Medical Center·interventional·Posted Aug 1, 2023·Updated Apr 30, 2026

In Brief

A clinical study evaluating Podimetrics SmartMat for Diabetic Foot Ulcer. Completed, enrolled 20 participants across 1 site.

Detailed Summary

The investigator team will study the adherence of the participant cohort to a non significant risk device over a six month period. The device is a foot mat, which can detect changes in foot temperature that may predict foot ulceration in patients with diabetes mellitus. This mat, the Podimetrics Smart Mat, is FDA cleared.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDiabetic Foot Ulcer
CountriesUnited States
CollaboratorsPodimetrics, Inc., National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), American Diabetes Association

Timeline

N/ACompletedFinished
202420252026
First PostedAug 1, 2023
Enrollment StartJul 3, 2024
Primary CompletionApr 3, 2025
TodayJul 2, 2026
Enrollment to primary: 9 monthsPosted 2.9 years ago

Interventions

Podimetrics SmartMatdevice

Participants receive training for stepping on SmartMat each day for 6 months. Monthly phone calls will be conducted to assess foot health and mat.